Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT138708021388N1Phase 3Completed
Phase 3 trial of tranexamic acid in perioperative hemorrhage, sponsored by Guilan University of Medical Sciences. Primary endpoint: Intraoperative blood loss volume. Started Dec 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT138708021388N1.